Peer Review History
| Original SubmissionOctober 12, 2023 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-23-29600Effect of Implementing of the Integrate Discharge Model on Satisfaction of Patient Referred to Trauma Emergency DepartmentPLOS ONE Dear Dr. Ghafouri, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Milad Khorasani, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "No" At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in your Competing Interests section: "NO authors have competing interests". Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. We note that your Data Availability Statement is currently as follows: "All relevant data are within the manuscript and its Supporting Information files." Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 5. We are unable to open your Supporting Information file "Data.sav". Please kindly revise as necessary and re-upload. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1- Please compare your survey to similar surveys in the literature. 2- Please mention the weak and strong points of your study 3- I recommend the authors discuss following article in the discussion: I- Sarbazi E, Sadeghi-Bazargani H, Farahbakhsh M, Ala A, Soleimanpour H. Psychometric properties of trust in trauma care in an emergency department tool. Eur J Trauma Emerg Surg. 2023 Aug 21. doi: 10.1007/s00068-023-02348-z. II- Rahmani F, Rezazadeh F, Ala A, Soleimanpour M, Mehdizadeh R, Soleimanpour H. Evaluation of Overcrowding of Emergency Department in Imam Reza Hospital in 2015 by Implementing 2 Scales: NEDOCS and EDWIN. Iran Red Crescent Med J. 2017 June; 19(6):e15609. III- Soleimanpour H, Gholipouri C, Salarilak S, Raoufi P, Vahidi RG, Rouhi AJ, Ghafouri RR, Soleimanpour M. Emergency department patient satisfaction survey in Imam Reza Hospital, Tabriz, Iran. Int J Emerg Med. 2011 Jan 27;4:2. doi: 10.1186/1865-1380-1-2. Reviewer #2: I reviewed the article entitled “Effect of Implementing of the Integrate Discharge Model on Satisfaction of Patient Referred to Trauma Emergency Department” by Kalaiee et al. submitted to PLOS ONE (Manuscript Number: PONE-D-23-29600). In this observational study involving 86 injured patients, the authors mainly investigated that the effect of implementing of the integrate discharge model on patients' satisfaction. They found that implementing of the integrate discharge model was associated with the increased patients' satisfaction, measured by self-reported questionnaire. From these observations, they claimed the usefulness of integrated discharge model in patients with trauma. First, the reviewer pays respect for the Authors' tremendous effort spent on this manuscript. However, there are numerous concerns with the data presentation, design as well as the methodology. My concerns are listed below: 1 Much of the abstract is currently spent on background and methods. Please provide in the abstract an informative and balanced summary of what was done and what was found. At the current form, description regarding results is poor, and intervention used in this study is not clear enough. 2 This observational study does not follow STROBE Statement Guidelines (https://www.equator-network.org/reporting-guidelines/strobe/). The authors should respect the basic rule of scientific writing. 3 Please indicate the study’s design with a commonly used term in the title, according to the STROBE check list. The title also should be more specific. One example is therefore “Effect of Implementing of the Integrate Discharge Model on Satisfaction of Patient Referred to Trauma Emergency Department: a retrospective observational study at a single medical institution in Iran" Introduction 4 At the introduction section, the authors should clarify how the information collected can be used to solve the current problems for trauma. 5 At the end of the introduction section, please state the any prespecified hypotheses according to the STROBE check list. Methods 6 Please describe settings and locations more in details (e.g. a tertiary hospital, academic hospital, referral trauma center, number of hospital and ICU beds, and number of annual trauma admission, etc.) where the data were collected. This information should help readers to depict the context of this study more accurately. This reviewer thinks annual trauma volume is especially important because it can greatly affect the quality of trauma care [1, 2], and may be confounding factors in the analyses. 7 The Ethical approval section should include the relevant date of the approval. 8 The authors should describe the intervention used in this study greater in details. As the current form, it is difficult to replicate your study even by other skilled researchers. 9 Please give the characteristic of the data source. How did you assure the quality of data? Since this is an observational study, quality assurance is of vitally important. 10 Study period was just half ot the year (January to July, 2023. Why did you employ such short duration? 11 Clearly define all exposures, predictors, potential confounders, and effect modifiers. 12 Describe all statistical methods, including those used to control for confounding. 13 Describe any efforts to address potential sources of bias, according to the STROBE checklist. For example, blinding is one of the attractive methods to reduce above mentioned biased assessment. If done, please provide who was blinded and how. 14 Who planned this study, who collected data, and who conducted the statistical analysis? I think if the same researchers are involved in study planning, data collecting, outcome measurement, and statistical analysis, there is a theoretical risk of biased assessment. 15 The authors did not provide the information how the questionnaire used here was developed. How did you assure the scientific validity of this survey? As is the current form, the reviewer and readers of this journal cannot judge whether the questionnaire used here is validated or not. This reviewer thinks planning phase is the most important process of the survey that requires detailed description. How did you select the items of your questionnaires? Did you referred to relevant studies conducted in other countries or other setting when developing the questionnaire? In addition, the authors should provide the rationale of outcome measurements. 16 Please provide the rationale of the items included in this survey more in details. 17 Please provide an English version of the full questionnaires used in this study to facilitate readers' understanding regarding this project. 18 The authors should describe relevant dates, including periods of questionnaires development, questionnaires distribution, follow up, and collection. 19 Please explain how missing data were addressed. Did authors use complete dataset? 20 A flow diagram reporting the numbers of individuals at each stage of study—eg numbers potentially eligible, is missing. 22 Table 1. Baseline characteristics of the participants Many vital information is missing. Give characteristics of study participants such as vital sings including GCS score, blood pressure, and respiratory rate, need of endotracheal intubation and mechanical ventilation, Charlson Comorbidity Index, trauma etiology (penetrating or blunt), Abbreviated Injury Scale of each body parts, TRISS based probability of survival etc. At this current form, many readers including myself find it difficult to image the characteristics of study subjects. In addition, these variables would have confounded the results. There are too many unmeasured confounders. This is the serious flaw of your manuscript. The authors should adjust for such important confounders to provide more reliable data. Discussion 23 Much of the discussion section is simply the list of previous studies, restate or rephrase the results and background that have already described in results and introduction section. Most parts of discussion are too speculative, and not based on the data obtained in this study. This reviewer thinks the discussion is not thought evoking one. In addition, the discussion section should indicate how the findings of this study can be used to solve the current problems. How and for what do we use these results presented here to improve the current trauma care and why? 24 The limitation section needs substantial revision. Please discuss limitations of the study, taking into account sources of potential bias or imprecision. Consider the important limitations and do not just list them but consider their relevance and how they might bias the results. Discuss both direction and magnitude of any potential bias. 25 What is the strength of this observational study? Please indicate after the limitation section. 26 Please discuss the generalizability (external validity) and potential clinical implications for practice of the study results. 27 Please indicate future research direction more in details, immediately after limitation section. Conclusion 28 The conclusion section is just rephrased of the observed findings. The study implications are not shown in the conclusion section. How to use this conclusion to improve the clinical outcome of the patients? Please indicate. Minor points 29 Keep abbreviations to a minimum. Do not use non-standard abbreviations unless they appear at least three times in the text. 30 The authors should provide the minimal anonymized data set used in this manuscript, according to the journal's policy. Although the number of criticisms listed above, this reviewer should however state that it is laudable that this work is derived from huge efforts made by the authors, who are working as the frontline healthcare professionals. The reviewer respects the authors’ time and effort spent on this manuscript, and the authors ‘patience and professionalism in dealing with my comments. References 1. MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO.A national evaluation of the effect of trauma-center care on mortality.N Engl J Med. 2006,26;354:366-78. 2. Minei JP, Fabian TC, Guffey DM, Newgard CD, Bulger EM, Brasel KJ, Sperry JL, MacDonald RD. Increased trauma center volume is associated with improved survival after severe injury: results of a Resuscitation Outcomes Consortium study. Ann Surg. 2014, 260:456-64. Reviewer #3: The main problem of this manuscript is the ambiguity in the sampling method, the method of randomly assignment of samples to control and test groups. When and by whom were the samples selected? The formula for calculating the sample size is not clear and numbers have not been placed in it? The numerical value of alpha and sigma is not mentioned. Considering the nature of the emergency department and the short stay of patients, has it been possible to train them? What was the role of caregivers in this study and why was it not included in the statistical analysis? Also, this manuscript needs basic revision in terms of written English language. In table number 1, the sum of control and test samples is not correct in some parts. Finally, many of the references are old, and if possible, newer references should be used instead them. Reference number 16 does not have the year of publication. The reference writing format style needs to be edited. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Esmail Khodadadi ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-29600R1Effect of Implementing of the IDEAL Discharge Model on Satisfaction of Patient Referred to Trauma Emergency DepartmentPLOS ONE Dear Dr. Ghafouri, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Milad Khorasani, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The respected authors revised the article in the best manners. The article is suitable for publication. Reviewer #3: Congratulations on your perfect work. The reviewer's comments revision seems to have been well done. Your study is beneficial for Health professionals in Emergency Department in Hospitals. Reviewer #4: Abstract: Further review by an English native speaker is needed. e.g. "Eighty-size patients were participated" should be Eighty-six patients participated. and this sentence should mention the patients were recruited between these dates, rather than all patients involved the whole period. Some methods are specified in the results section, include independent t-test in the methods (but shouldn't it be a paired t-test as each patient has a pre and post value? Please specify the statistical methods used and confirm they were appropriate. Methods pg 5: why was it a quasi-experimental interventional study? Isn't it an interventional study? line 111: 3,0000 is not the standard way a number is presented: do you mean 30,000? Power calculation: what is the difference of 10 between. Clarify if it in the mean overall score between groups at the discharge visit? you state in the text d=10 unites, but then on line 133 it is 1.25. Please clarify. line 135 has too many equals signs, and how does 40/14 = 40? line 140: matched: this means different things statistically and in a sampling manner. How did it work - the matching - was it used to recruit particular participants in the second group? Was it a coincidence that both groups went from 50 to 43? i.e. did recruitment stop when the 43rd patient completed study assessments? pg 11 - the first paragraph seems to be explaining the acronym IDEAL - the EAL is clear, but what about the I and D? line 233 and 237 and 241: should this be p>0.05? units for time in emergency room? table 3: is satisfaction of the emergency department made up of the sum of the other 6 or 7 elements? This needs to be clearer in the methods section, and state that this is the primary endpoint, secondary tests are done for individual components of the score. I had thought the primary quantity of interest was the satisfaction at discharge time (after the intervention had occurred in the intervention group). Please clarify for all readers. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: Yes: Dr. Esmail Khodadadi Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-23-29600R2Effect of Implementing of the IDEAL Discharge Model on Satisfaction of Patient Referred to Trauma Emergency DepartmentPLOS ONE Dear Dr. Ghafouri, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please submit your revised manuscript by Jun 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Milad Khorasani, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: Thank you for the revised manuscript. It is clearer and easier to understand now. line 241 in track changed version: what is the unit for time in the emergency room? Assume minutes or hours, but please state clearly. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Effect of Implementing of the IDEAL Discharge Model on Satisfaction of Patient Referred to Trauma Emergency Department PONE-D-23-29600R3 Dear Dr. Ghafouri, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Milad Khorasani, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: No ********** |
| Formally Accepted |
|
PONE-D-23-29600R3 PLOS ONE Dear Dr. Ghafouri, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Milad Khorasani Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .